Objectives:to verify the prevalence of arterial hypertension and its risk factors among
people with acquired immunodeficiency syndrome under antiretroviral therapy.
Method:cross-sectional study with 208 patients. Data collection was conducted
through interviews using a form containing data on sociodemographic,
clinical and epidemiological aspects, hypertension risk factors, blood
pressure, weight, height, body mass index and abdominal circumference. Mean,
standard deviation, odds ratio and confidence interval were calculated,
t-test and Chi-square test were used, considering P < 0.05 as
statistically significant. Hypertension associated variables were selected
for logistic regression. Results:patients were male (70.7%), self-reported as mixed-race (68.2%), had
schooling between 9 and 12 years of study (46.6%), had no children (47.6%),
were single (44.2%), in the sexual exposure category (72.1%) and
heterosexual (60.6%). The prevalence of people with acquired
immunodeficiency syndrome and arterial hypertension was 17.3%. Logistic
regression confirmed the influence of age greater than 45 years, family
history of hypertension, being overweight and antiretroviral therapy for
more than 36 months for hypertension to occur. Conclusion:the prevalence of hypertension was 17.3%. Patients with acquired
immunodeficiency syndrome and hypertension were older than 45 years, had
family history of hypertension, were overweight and under antiretroviral
therapy for more than 36 months.